REQUEST A DEMO
Total
USD $0.00
Search more companies

Transcenta Holding Limited (Hong Kong) (创胜集团医药有限公司 (香港)) (China)

Main Activities: Pharmaceutical and Medicine Manufacturing | Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Transcenta Holding Limited Profile Updated: December 11, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Chinese Download a sample report

Transcenta Holding Limited (Hong Kong) (创胜集团医药有限公司 (香港)) is based in China. The head office is in Suzhou. It operates in the Pharmaceutical and Medicine Manufacturing industry. It was established on August 20, 2010. There are currently 184 (2024) people employed by Transcenta Holding Limited (Hong Kong) (创胜集团医药有限公司 (香港)). From the latest financial highlights, Transcenta Holding Limited (Hong Kong) (创胜集团医药有限公司 (香港)) reported a net sales revenue drop of 40.6% in Q2C2025. A negative growth of 29.5% was recorded in its total assets. The net profit margin of Transcenta Holding Limited (Hong Kong) (创胜集团医药有限公司 (香港)) decreased by 1119.68% in 2025.

Headquarters
B6-501, 218 Xinghu Street, Biobay
Suzhou; Jiangsu; Postal Code: 215123

Contact Details: Purchase the Transcenta Holding Limited (Hong Kong) (创胜集团医药有限公司 (香港)) report to view the information.

Website: http://www.transcenta.com

Basic Information
Total Employees:
Purchase the Transcenta Holding Limited (Hong Kong) (创胜集团医药有限公司 (香港)) report to view the information.
Outstanding Shares:
Purchase the Transcenta Holding Limited (Hong Kong) (创胜集团医药有限公司 (香港)) report to view the information.
Registered Capital:
Purchase the Transcenta Holding Limited (Hong Kong) (创胜集团医药有限公司 (香港)) report to view the information.
Financial Auditors:
Purchase the Transcenta Holding Limited (Hong Kong) (创胜集团医药有限公司 (香港)) report to view the information.
Incorporation Date:
August 20, 2010
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Chief Executive Officer
Purchase this report to view the information.
Chief Financial Officer
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Secretary
Ownership Details
Purchase this report to view the information.
9.03%
Purchase this report to view the information.
8.39%
Purchase this report to view the information.
7.73%
Purchase this report to view the information.
5.96%
Purchase this report to view the information.
5.14%
Subsidiaries
Mabspace Biosciences Co., Limited (Hong Kong SAR, China)
100%
Transcenta Biotherapeutics Inc. (United Kingdom)
100%
Transcenta Therapeutics Inc. (United States)
100%
Company Performance
Financial values in the chart are available after Transcenta Holding Limited (Hong Kong) (创胜集团医药有限公司 (香港)) report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CNY. Absolute financial data is included in the purchased report.
Net sales revenue
-40.6%
Total Operating Revenue
9.16%
Operating Profit
23.66%
EBITDA
27.72%
Net Profit/Loss for the Period
17.9%
Total Assets
-29.5%
Total Equity
-27.7%
Operating Profit Margin
-786%
Net Profit Margin
-1119.68%
Return on Equity (ROE)
-2.02%
Debt / Equity
-7164%
Quick Ratio
-605.15%
Cash Ratio
-0.65%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?